Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
ADVERTISEMENT FEATUREAdvertiser retains sole responsibility for the content of this article
Taking RNAi under the skin
The potential of gene silencing via RNAi has long been recognized, and innovations in the delivery of RNAi therapeutics by Dicerna Pharmaceuticals have enabled potent, long-acting gene silencing with a single subcutaneous injection for liver-associated diseases.